J
jilly4ski
Guest
In a move utterly devoid of shock value to Catholics who have been paying attention at all, the Vatican has announced plans to fund NeoStem, a small adult stem cell research company in New York. According to the Los Angeles Times,
Code:[NeoStem CEO Dr. Robin] Smith . . . was quick to emphasize that the Vatican is not investing in her company, which is publicly traded on the New York Stock Exchange. Most of the collaboration will involve a nonprofit company established by NeoStem, the Stem for Life Foundation, she said. The Vatican’s role will include fundraising, launching educational campaigns, contributing to research and sponsoring the Rome conference, Smith said.
Lol
My favorite line of the article.
And yet the field has shown mixed results, if by “mixed results” you mean “dismal and unmitigated failure.” When asked to list “diseases cured by embryonic stem cell therapy,” Google Chrome said, “Aw, snap. The information you are looking for does not appear to exist.” It then asked, “Did you mean ‘adult stem cell cures?’” and offered 13,700,000 results.